DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.00 Cr | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹8.00 Cr |
| Mar2025 | ₹8.00 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹89 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.00 Cr | 0.00 | |
| Mar2025 | ₹8.00 Cr | -96.89 | |
| Mar2024 | ₹257 Cr | 188.76 | |
| Mar2023 | ₹89 Cr | -0.03 | |
| Mar2022 | ₹89 Cr | - | |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹192,398.6 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1% |
7.3% |
7.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses